Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Bimekizumab effectively treated a man's chronic beard hair loss.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Future acne treatments should aggressively target inflammation to prevent scarring.

New acne treatments show promise as alternatives to traditional therapies.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

TNF-alpha inhibitors can cause various immune-related skin issues.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Gray hair can potentially be reversed, leading to new treatments.

IL-17-producing γδ T cells help improve bone healing.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Probiotic bacteria improved skin and hair health in aged mice.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Hair follicles play a crucial role in regulating skin barrier function.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.